Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 12,601 shares at $50.42 ($635K) on 2024-01-17, disclosed to the SEC on 2024-01-18.
Seasonal sale ($635k) by EVP Research — this insider has traded IONS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.42 | 9 | $454 | 0.1% |
| 2 | $50.42 | 6,296 | $317K | 50.0% |
| 3 | $50.42 | 6,296 | $317K | 50.0% |
| Total | $50.42 avg | 12,601 | $635K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |